Haemonetics Corp. (HAE)
59.43
+0.42
(+0.71%)
USD |
NYSE |
Apr 30, 13:08
Haemonetics Profit Margin (Quarterly) : 13.20% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 25.74% |
| Edwards Lifesciences Corp. | 23.09% |
| QuidelOrtho Corp. | -18.07% |
| Stryker Corp. | 11.84% |
| Zimmer Biomet Holdings, Inc. | 11.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.07% |
| Return on Assets | 7.09% |
| Return on Invested Capital | 8.31% |
| Gross Profit Margin (Quarterly) | 56.47% |
| Operating Margin (Quarterly) | 20.52% |
| Return on Net Operating Assets | 9.20% |